Posted by Michael Wonder on 28 Sep 2017
Lannett receives FDA approval for oxycodone and acetaminophen tablets, 5 mg/325 mg and 10 mg/325 mg
27 September 2017 - Lannett today announced that it received approval from the U.S. FDA of its abbreviated new drug application for oxycodone and acetaminophen tablets, USP, 5 mg/325 mg and 10 mg/325 mg, the therapeutic equivalent to the reference listed drug, Percocet tablets, 5 mg/325 mg and 10 mg/325 mg, of Vintage Pharmaceuticals.
For the 12 months ended July 2017, total U.S. sales of oxycodone and acetaminophen tablets, USP, 5 mg/325 mg and 10 mg/325 mg, at average wholesale price were approximately $571 million, according to IMS.
